Is ProShares Ultra Health Care overvalued?

ProShares Ultra Health Care (RXL) — key valuation metrics and fundamentals.

No verdict

Price

$53.45

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$108.2M

Dividend yield

—

Return on equity

—

Sector

Financial Services

Fair value compares RXL's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 30 Jun 2026.

Related stocks